Meiji Yasuda Asset Management Co Ltd. bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,687 shares of the company’s stock, valued at approximately $905,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of Corteva during the 2nd quarter worth approximately $4,560,180,000. Harris Associates L P raised its holdings in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Norges Bank purchased a new position in Corteva during the fourth quarter valued at $504,001,000. Royal Bank of Canada grew its position in shares of Corteva by 202.1% in the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after buying an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp bought a new position in shares of Corteva in the 2nd quarter worth about $392,447,000. Institutional investors own 81.54% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. CICC Research boosted their price target on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $101.00 price target on shares of Corteva in a research report on Monday, August 3rd. Citigroup lifted their target price on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Mizuho boosted their target price on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Finally, BMO Capital Markets increased their price objective on shares of Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.
Corteva Price Performance
Shares of NYSE:CTVA opened at $83.18 on Wednesday. The company has a market capitalization of $55.50 billion, a P/E ratio of 55.09, a P/E/G ratio of 2.54 and a beta of 0.57. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The firm’s 50 day simple moving average is $82.39 and its two-hundred day simple moving average is $80.37. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.
Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm’s revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio is presently 47.68%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
